• Profile
Close
Sign Up / Log In
Journal Summaries
Family Medicine
  Clinical Pharmacology

Initiation of dapagliflozin and treatment-emergent fractures

Diabetes, Obesity and Metabolism | Dec 06, 2017 Clinical Pharmacology

Weekly cabazitaxel plus prednisone is effective and less toxic for 'unfit' metastatic castration-resistant prostate cancer: Phase II Spanish Oncology Genitourinary Group (SOGUG) trial

European Journal of Cancer | Dec 05, 2017 Clinical Pharmacology

Effectiveness and tolerability of therapy with exenatide once-weekly vs basal insulin among injectable-naïve elderly or renal impaired patients with type 2 diabetes in the United States

Diabetes, Obesity and Metabolism | Dec 05, 2017 Clinical Pharmacology

Capecitabine and oxaliplatin as first and second line treatment for locally advanced and metastatic pancreatic ductal adenocarcinoma

Journal of Gastrointestinal Oncology | Dec 05, 2017 Clinical Pharmacology

COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss

European Journal of Cancer | Dec 04, 2017 Clinical Pharmacology

Long-term clinical efficacy and safety of secukinumab for Japanese patients with psoriasis: A single-center experience

The Journal of Dermatology | Dec 04, 2017 Clinical Pharmacology

Efficacy and safety of twice-daily rabeprazole maintenance therapy for patients with reflux esophagitis refractory to standard once-daily proton pump inhibitor: The Japan-based EXTEND study

Journal of Gastroenterology | Dec 03, 2017 Clinical Pharmacology

A prospective study of docetaxel-associated pain syndrome

Supportive Care in Cancer | Dec 03, 2017 Clinical Pharmacology

Vemurafenib for BRAF V600–mutant Erdheim-Chester disease and Langerhans cell histiocytosis: Analysis of data from the histology-independent, phase 2, open-label VE-BASKET study

JAMA Oncology | Dec 03, 2017 Clinical Pharmacology

Dual therapy with darunavir and ritonavir plus lamivudine vs triple therapy with darunavir and ritonavir plus tenofovir disoproxil fumarate and emtricitabine or abacavir and lamivudine for maintenance of human immunodeficiency virus type 1 viral suppression: Randomized, open-label, noninferiority DUAL-GESIDA 8014-RIS-EST45 trial

Clinical Infectious Diseases | Dec 02, 2017 Clinical Pharmacology

1 … 323 325 327 … 393
Most read this week
1

Article on Monitoring Nutritional Status in Hospitalised Patients: A Physician’s Guide
Placeholder
2

MD Clip on The Role of Lifestyle Medicine in Slowing Biological Ageing by Dr Agasti
Placeholder
3

Article on Genomic Libraries for Genetic Enhancement: A Healthier Future?
Placeholder
4

Article on Ralstonia in Blood Cultures: Clinical Relevance of a Rare and Emerging Pathogen
Placeholder
Bannerimg

A variety of information related to Medicine and Health Care. It's all here.

Select Topic

x
M3 app logo
Choose easy access to M3 India from your mobile!

Add to home

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay